Literature DB >> 19577329

Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis.

Athanasios Tsianakas1, Jan M Ehrchen, Dagmar Presser, Tobias Fischer, Birgit Kruse-Loesler, Thomas A Luger, Cord Sunderkoetter.   

Abstract

Giant cell arteritis (GCA) is a systemic vasculitis associated with severe complications such as loss of vision and, rarely, scalp necrosis. We present a patient with GCA who had bilateral scalp necrosis and an erythrocyte sedimentation rate of only 21 mm after the first hour. Therapy with systemic steroids, which were slowly tapered over 1 year, led to secondary wound healing without recurrence. As there are no systematic reviews on the occurrence of scalp necrosis in patients with GCA, we performed a literature research and meta-analysis and discovered 78 cases published between 1946 and 2007. Analysis of the data revealed that GCA with scalp necrosis is associated with a higher incidence of vision loss (32%) and other visual defects (37.3%) than GCA without scalp necrosis (visual disturbances in up to 20%). GCA with scalp necrosis is also associated with an increased mortality (standard mortality ratio [SMR], 4.2) in contrast to GCA without scalp necrosis, which has no significantly higher mortality than age-matched controls (SMR 0.8-1.034). In patients with scalp necrosis, the diagnosis of GCA was made about 1 month later than in patients without scalp necrosis, and scalp necrosis was never reported to occur after onset of therapy with glucocorticoids. Thus, for reasons beyond potential loss of vision, physicians should be alert for symptoms of GCA as only timely diagnosis and immediate therapy may prevent serious complications and increased mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19577329     DOI: 10.1016/j.jaad.2008.11.913

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  Bilateral scalp necrosis as a rare but devastating complication of giant cell arteritis.

Authors:  Q Akram; S Knight; R Saravanan
Journal:  Clin Rheumatol       Date:  2014-10-17       Impact factor: 2.980

Review 2.  Giant Cell Arteritis: Practical Pearls and Updates.

Authors:  Swati Pradeep; Jonathan H Smith
Journal:  Curr Pain Headache Rep       Date:  2018-01-17

3.  [Bitemporal scalp necrosis : a very rare manifestation of giant cell arteritis].

Authors:  E M Valesky; M Wahle; S Vranes; M Wolter; R Kaufmann; M Meissner
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

Review 4.  [Skin manifestations of different forms of vasculitis].

Authors:  C Sunderkötter
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

Review 5.  [Cutaneous symptoms of various vasculitides].

Authors:  C Sunderkötter; K I Pappelbaum; J Ehrchen
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

6.  Forehead necrosis, one of the many facades of giant cell arteritis.

Authors:  Vanessa Elizabeth Palmer; Tafadzwa Young-Zvandasara; Bharati Vusirikala
Journal:  BMJ Case Rep       Date:  2015-05-07

7.  Spinal cord infarction in giant cell arteritis associated with scalp necrosis.

Authors:  Khader N Mustafa; Azmy Hadidy; Anwar Joudeh; Fatima Nouri Obeidat; Khalid W Abdulfattah
Journal:  Rheumatol Int       Date:  2014-07-18       Impact factor: 2.631

Review 8.  Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.

Authors:  Francois Chasset; Camille Francès
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

9.  Cutaneous nocardiosis manifesting as a frontal mass in a patient with giant cell arteritis.

Authors:  Violeta Tincuta Briciu; Mirela Flonta; Mihaela Lupse; Laura Damian
Journal:  Clujul Med       Date:  2017-04-25

10.  Bitemporal scalp, lip and tongue necrosis in giant cell arteritis: a rare presentation.

Authors:  Rajesh Kumar; Hemant Gupta; Anil Jadhav; Sv Khadilkar
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.